The FDA has issued a warning based on 20 reported cases of ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors for type 2 diabetes.
In the ILLUMINATE-C trial, patients with advanced primary hyperoxaluria type 1 and severe renal impairment treated with lumasiran showed decreased plasma oxalate and good safety profiles at 6 months and 12...
In this COVID-19 roundup, the CDC reports a record low number of COVID-19 hospitalizations, metformin reduces the likelihood of SARS-CoV-2 Viral load and rebound, Remdesivir reduces mortality in older...
Authors of a new study say they have determined how Salmonella typhi, a multidrug-resistant strain of typhoid, has surfaced and spread throughout the past 30 years, reaching a stage that may now represent...